Amir Safavi, Radiation Oncology Fellow at Memorial Sloan Kettering Cancer Centre ,shared a post on X:
“Risk mitigation strategies for ultracentral lung tumors in IJROBP – The Red Journal:
- Moderate plan dmax (eg 110-120%).
- Limit OAR hotspots (esp Esophagus).
- Avoid overly generous PTV.
- Nodes treated cooler (eg 35/5) Accurate target and OAR contouring (use contrast).“Beyond the HILUS Trial: How Can We Improve the Safety of SABR for Ultracentral Thoracic Tumors?Authors: Amir H. Safavi, David A. Palma and
Source: Amir Safavi/X
